An integrated breast cancer transcriptomic atlas defines clinical subtypes and informs cellular origin.
Efforts to analyze breast cancer transcriptomes at scale are hindered by cross-study technical variability. To overcome this challenge, we adapt single-cell RNA sequencing analytical strategies to harmonize 7,612 bulk breast cancer transcriptomes from 22 datasets, generating a high-resolution atlas that resolves both e...